Skip to Content

Illumina Inc

ILMN: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$364.00CfhvsgJwwqwhqh

Illumina Delivers Weak End to 2022 and Maintains Outlook for 2023; No Fair Value Change

After releasing preliminary 2022 results and 2023 guidance in January, narrow-moat Illumina released full quarterly results that represented a weak end to a miserable year. However, management maintained its guidance for 2023, and we retain our $269 fair value estimate. We still view shares as undervalued.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of ILMN so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center